High-dose methotrexate in childhood all

Pediatric Hematology and Oncology

Volumn 17, Issue 8, 2000, Pages 615-622

  Moe, Peter Johan ^a   Holen, Are ^b  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ALL; Childhood; HDM

Indexed keywords

ASPARAGINASE; CYTARABINE; FOLINIC ACID; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TENIPOSIDE; VINCRISTINE;

ACUTE LYMPHOCYTIC LEUKEMIA; BONE MARROW SUPPRESSION; CHILDHOOD CANCER; CLINICAL TRIAL; DRUG MEGADOSE; DRUG TOLERABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; MUCOSA INFLAMMATION; MULTICENTER STUDY; NORWAY; QUALITY OF LIFE; RELAPSE; REVIEW; TOXICITY TESTING; UNITED KINGDOM;

EID: 0033657707     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/08880010050211321     Document Type: Review

References (21)

1. The Berlin childhood acute lymphoblastic leukemia therapy study, 1970-1976
2. Risk of secondary tumors in survivors of childhood leukemia
3. On surviving childhood cancer: Late psychological consequences for patients, parents and siblings
4. Intensified treatment of acute lymphoblatic leukemia has improved prognosis, especially in non-high-risk patients: The Nordic experience of 2648 patients diagnosed between 1981 and 1996
5. Central nervous system treatment prophylaxis with high dose methotrexate: A pharmakinetic and clinical study: Result of protocol FRALLE 89
6. Treatment of acute lymphocytic leukemia by high-dose intravenous methotrexate
7. Intermediate dose methotrexate in childhood acute lymphocytic leukemia
8. 2/24 hrs) in childhood acute lymphocytic leukemia: A pilot study
9. Intensified treatment of acute lymphoblastic leukemia has improved prognosis, especially in non-high-risk patients
10. Comparison of high dose methotrexate with continuing intrathecal methotrexate versus intrathecal methotrexate alone in low white blood count in childhood lymphoblastic leukemia: Preliminary results from the UKALL XI randomized trial
11. Intermediate dose methotrexate is as effective as high dose methotrexate in preventing isolated testicular relapse in childhood acute lymphocytic leukemia
12. The treatment of childhood acute lymphoblastic leukemia. The International BFM study group experience
13. Central nervous system preventive therapy with systemic high dose methotrexate versus cranial irradiation and intrathecal methotrexate: Longitudinal comparison of effects of treatment on intellectual function of children with acute lymphoblastic leukemia
14. Central nervous system preventive treatment with systemic high dose methotrexate versus cranial irradiation and intrathecal methotrexate: Comparison of effects of treatment on academic achievment in children with acute lymphoblastic leukemia
15. High cure rate with a moderately intensive treatment regimen in non-high risk childhood acute lymphoblatic leukemia: Results of protocol ALL V1 from the Dutch Child hood Leukemia Study Group
16. Central nervous system treatment in childhood acute lymphoblastic leukemia: Long-term follow-up in patients diagnosed between 1973 and 1985
17. Neurologic sequelae of methotrexate and ionizing radiation: A new classification
18. CNS chemoradiotherapy of childhood leukemia: The plot thickens but the ending bodes well
19. Evaluation of serious adverse effects in patients treated with protocols including methotrexate infusions
20. Magnetic resonance imaging and neurological evaluation after treatment with high-dose methotrexate for acute lymphocytic leukemia in young children
21. Second malignant neoplasms in patients treated for childhood leukemia